Investor Presentaiton
Safe harbor and non-GAAP disclosures
INVESTOR 20
DAY 23
Certain statements in this presentation and the accompanying oral commentary are forward-looking
statements within the meaning of federal securities laws. These statements relate to future events or
Guardant Health, Inc. (the "Company")'s future results and involve known and unknown risks,
uncertainties and other factors that may cause the actual results, levels of activity, performance or
achievements of the Company or its industry to be materially different from those expressed or implied
by any forward-looking statements. In some cases, forward-looking statements can be identified by
terminology such as "may," "will," "could," "would," "should," "to," "target," "expect," "plan," "anticipate,"
"intend," "believe," "estimate," "predict," "potential" or other comparable terminology. All statements other
than statements of historical fact could be deemed forward-looking, including any expectations
regarding the Company's commercial engine as a force multiplier for research and development
initiatives; any projections of market opportunities; statements about the Company's ability to assess
potential market opportunities or any statements about the Company's ability to successfully develop
new products and services; any statements regarding expectations for future reimbursement
opportunities; any statements regarding the Company's long-term expectations, including with respect to
oncology, liquid biopsy, and other aspects of the Company's industry; any statements about launching
planned new products and additional laboratories, including with respect to Guardant Reveal, CGP tissue
assay, and laboratories outside the United States; any statements about the Company's ECLIPSE study;
any statements regarding expectations for future regulatory approvals; any statements about historical
results that may suggest trends for the Company's business; any statements of the plans, strategies, and
objectives of management for future operations and directions; any statements of expectation or belief
regarding future events, opportunities to drive future growth, potential markets or market size, or
technology developments; and any statements of assumptions underlying any of the items mentioned.
The Company has based these forward-looking statements on its current expectations, assumptions,
estimates and projections. While the Company believes these expectations, assumptions, estimates and
projections are reasonable, such forward-looking statements are only predictions and involve known and
unknown risks and uncertainties, many of which are beyond the Company's control. These and other
GUARDANT
important factors may cause actual results, performance or achievements to differ materially from those
expressed or implied by these forward-looking statements. The forward-looking statements in this
presentation are made only as of the date hereof. For a further description of the risks and uncertainties
that could cause actual results to differ from those expressed in these forward-looking statements, as
well as risks relating to the business of the Company in general, see the Company's periodic filings with
the Securities and Exchange Commission, including its Annual Report on Form 10-K for the year ended
December 31, 2022, and in its other reports filed with or furnished to the Securities and Exchange
Commission. Except as required by law, the Company assumes no obligation and does not intend to
update these forward-looking statements or to conform these statements to actual results or to changes
in the Company's expectations.
This presentation also contains estimates and other statistical data made by independent parties and by
the Company relating to market size, penetration and growth and other data about the Company's
industry, which involve a number of assumptions and limitations, and you are cautioned not to give
undue weight to such estimates. In addition, projections, assumptions, and estimates of the Company's
future performance and the future performance of the markets in which the Company operates are
necessarily subject to a high degree of uncertainty and risk.
In light of the foregoing, investors are urged not to rely on any forward-looking statement or third-party
data in reaching any conclusion or making any investment decision about any securities of the
Company.
This presentation includes references to certain financial measures that are not calculated in
accordance with GAAP. Reconciliation to the most directly comparable GAAP financial measure may be
found in our most recent earnings release furnished to the SEC on August 3, 2023.
3View entire presentation